The role of oxysterols in vascular ageing

Journal of Physiology

Volumn 594, Issue 8, 2016, Pages 2095-2113

  Gargiulo, Simona ^a   Gamba, Paola ^a   Testa, Gabriella ^a   Leonarduzzi, Gabriella ^a   Poli, Giuseppe ^a  

^a UNIVERSITY OF TURIN   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

22 HYDROXYCHOLESTEROL; 25 HYDROXYCHOLESTEROL; 26 HYDROXYCHOLESTEROL; 7 OXOCHOLESTEROL; 7ALPHA HYDROXYCHOLESTEROL; 7BETA HYDROXYCHOLESTEROL; ALPHA TOCOPHEROL; ASCORBIC ACID; OXIDIZED LOW DENSITY LIPOPROTEIN; OXYSTEROL;

AGING; APOPTOSIS; ARTERIAL STIFFNESS; ARTERY INTIMA PROLIFERATION; ATHEROSCLEROSIS; BLOOD VESSEL CALCIFICATION; CELL DEATH; CELL MIGRATION; CELL PROLIFERATION; DRUG EFFECT; ENDOTHELIAL DYSFUNCTION; ENDOTHELIUM CELL; HUMAN; INFLAMMATION; LIPID STORAGE; MONOCYTE; NONHUMAN; OXIDATIVE STRESS; PATHOGENESIS; PRIORITY JOURNAL; REVIEW; SMOOTH MUSCLE CELL; VASCULAR AGING; ANIMAL; CHEMISTRY; GROWTH, DEVELOPMENT AND AGING; METABOLISM; PATHOLOGY; VASCULAR ENDOTHELIUM;

AGING; ANIMALS; ATHEROSCLEROSIS; ENDOTHELIUM, VASCULAR; HUMANS; OXYSTEROLS;

EID: 84955612827     PISSN: 00223751     EISSN: 14697793     Source Type: Journal    
DOI: 10.1113/JP271168     Document Type: Review

References (125)

1. Annangudi SP, Deng Y, Gu X, Zhang W, Crabb JW & Salomon RG (2008). Low density lipoprotein has an enormous capacity to bind (E)-4-hydroxynon-2-enal (HNE): detection and characterization of lysyl and histidyl adducts containing multiple molecules of HNE. Chem Res Toxicol 21, 1384-1395.
2. Appukuttan A, Kassecker SA, Kumar S, Reusch HP & Ladilov Y (2013). Oxysterol-induced apoptosis of smooth muscle cells is under the control of a soluble adenylyl cyclase. Cardiovasc Res 99, 734-742.
3. Biasi F, Chiarpotto E, Sottero B, Maina M, Mascia C, Guina T, Gamba P, Gargiulo S, Testa G, Leonarduzzi G & Poli G (2013). Evidence of cell damage induced by major components of a diet-compatible mixture of oxysterols in human colon cancer CaCo-2 cell line. Biochimie 93, 632-640.
4. Biasi F, Mascia C, Astegiano M, Chiarpotto E, Nano M, Leonarduzzi G & Poli G (2009). Prooxidant and proapoptotic effects of cholesterol oxidation products on human colonic epithelial cells: a potential mechanism of inflammatory bowel disease progression. Free Radic Biol Med 47, 1731-1741.
5. Bosch-Marce M, Okuyama H, Wesley JB, Sarkar K, Kimura H, Liu YV, Zhang H, Strazza M, Rey S, Savino L, Zhou YF, McDonald KR, Na Y, Vandiver S, Rabi A, Shaked Y, Kerbel R, Lavallee T & Semenza GL (2007). Effects of aging and hypoxia-inducible factor-1 activity on angiogenic cell mobilization and recovery of perfusion after limb ischemia. Circ Res 101, 1310-1318.
6. Brandes RP, Weissmann N & Schröder K (2014). Nox family NADPH oxidases: Molecular mechanisms of activation. Free Radic Biol Med 76, 208-226.
7. Busse R & Fleming I (2006). Vascular endothelium and blood flow. Handb Exp Pharmacol 176, 43-78.
8. Buttari B, Segoni L, Profumo E, D'Arcangelo D, Rossi S, Facchiano F, Businaro R, Iuliano L & Riganò R (2013). 7-Oxo-cholesterol potentiates pro-inflammatory signaling in human M1 and M2 macrophages. Biochem Pharmacol 86, 130-137.
9. Carpenter KL, Kirkpatrick PJ, Weissberg PL, Challis IR, Dennis IF, Freeman MA & Mitchinson MJ (2003). Oral α-tocopherol supplementation inhibits lipid oxidation in established human atherosclerotic lesions. Free Radic Res 37, 1235-1244.
10. Catar R, Müller G, Heidler J, Schmitz G, Bornstein SR & Morawietz H (2007). Low-density lipoproteins induce the renin-angiotensin system and their receptors in human endothelial cells. Horm Metab Res 39, 801-805.
11. Catita J, López-Luppo M, Ramos D, Nacher V, Navarro M, Carretero A, Sánchez-Chardi A, Mendes-Jorge L, Rodriguez-Baeza A & Ruberte J (2015). Imaging of cellular aging in human retinal blood vessels. Exp Eye Res 135, 14-25.
12. Chaudhari N, Talwar P, Parimisetty A, Lefebvre d'Hellencourt C & Ravanan P (2014). A molecular web: endoplasmic reticulum stress, inflammation, and oxidative stress. Front Cell Neurosci 8, 213.
13. Chen J, Li D, Schaefer R & Mehta JL (2006). Cross-talk between dyslipidemia and renin-angiotensin system and the role of LOX-1 and MAPK in atherogenesis studies with the combined use of rosuvastatin and candesartan. Atherosclerosis 184, 295-301.
14. Cheng YW, Kang J, Shih YL, Lo YL & Wang C (2005). Cholesterol-3-beta, 5-alpha, 6-beta-triol induced genotoxicity through reactive oxygen species formation. Food Chem Toxicol 43, 617-622.
15. Cohen R, Plane F, Najibi S, Huk I, Malinski T & Garland C (1997). Nitric oxide is the mediator of both endothelium-dependent relaxation and hyperpolarization of the rabbit carotid artery. Proc Natl Acad Sci USA 94, 4193-4198.
16. Deanfield JE, Halcox JP & Rabelink TJ (2007). Endothelial function and dysfunction: testing and clinical relevance. Circulation 115, 1285-1295.
17. Deckert V, Brunet A, Lantoine F, Lizard G, Millanvoye-van Brussel E, Monier S, Lagrost L, David-Dufilho M, Gambert P & Devynck MA (1998). Inhibition by cholesterol oxides of NO release from human vascular endothelial cells. Arterioscler Thromb Vasc Biol 18, 1054-1060.
18. Deckert V, Perségol L, Viens L, Lizard G, Athias A, Lallemant C, Gambert P & Lagrost L (1997). Inhibitors of arterial relaxation among components of human oxidized low-density lipoproteins. Cholesterol derivatives oxidized in position 7 are potent inhibitors of endothelium-dependent relaxation. Circulation 95, 723-731.
19. Donato AJ, Morgan RG, Walker AE & Lesniewski LA (2015). Cellular and molecular biology of aging endothelial cells. J Mol Cell Cardiol 89, 122-135.
20. Duran MJ, Pierre SV, Lesnik P, Pieroni G, Bourdeaux M, Dignat-Georges F, Sampol J & Maixent JM (2010). 7-Ketocholesterol inhibits Na, K-ATPase activity by decreasing expression of its α1-subunit and membrane fluidity in human endothelial cells. Cell Mol Biol (Noisy-le-grand) 56, Suppl., OL1434-1441.
21. Farrokhi E, Samani K & Chaleshtori M (2015). Oxidized low-density lipoprotein increases bone sialoprotein expression in vascular smooth muscle cells via runt-related transcription factor 2. Am J Med Sci 349, 240-243.
22. Ferrario CM, Ahmad S, Nagata S, Simington SW, Varagic J, Kon N & Dell'italia LJ (2014). An evolving story of angiotensin-II-forming pathways in rodents and humans. Clin Sci (Lond) 126, 461-469.
23. Ferré N, Martinez-Clemente M, Lopez-Parra M, Gonzales-Periz A, Horrillo R, Planagumà A, Camps J, Joven J, Tres A, Guardiola F, Bataller R, Arroyo V & Clària J (2009). Increased susceptibility to exacerbated liver injury in hypercholesterolemic Apo-E deficient mice: potential involvement of oxysterols. Am J Physiol Gastrointest Liver Physiol 296, G553-G562.
24. Garcia-Cruset S, Carpenter KL, Guardiola F, Stein BK & Mitchinson MJ (2001). Oxysterol profiles of normal human arteries, fatty streaks and advanced lesions. Free Radic Res 35, 31-41.
25. Gargiulo S, Gamba P, Testa G, Sottero B, Maina M, Guina T, Biasi F, Poli G & Leonarduzzi G (2012). Molecular signaling involved in oxysterol-induced β1-integrin over-expression in human macrophages. Int J Mol Sci 13, 14278-14293.
26. Gargiulo S, Gamba P, Testa G, Rossin D, Biasi F, Poli G & Leonarduzzi G (2015). Relation between TLR4/NF-κB signaling pathway activation by 27-hydroxycholesterol and 4-hydroxynonenal, and atherosclerotic plaque instability. Aging Cell 14, 569-581.
27. Gargiulo S, Sottero B, Gamba P, Chiarpotto E, Poli G & Leonarduzzi G (2011). Plaque oxysterols induce unbalanced up-regulation of matrix metalloproteinase-9 in macrophagic cells through redox-sensitive signaling pathways: Implications regarding the vulnerability of atherosclerotic lesions. Free Radic Biol Med 51, 844-855.
28. Go YM, Halvey PJ, Hansen JM, Reed M, Pohl J & Jones DP (2007). Reactive aldehyde modification of thioredoxin-1 activates early steps of inflammation and cell adhesion. Am J Pathol 171, 1670-1681.
29. Gomez I, Foudi N, Longrois D & Norel X (2013). The role of prostaglandin E2 in human vascular inflammation. Prostaglandins Leukot Essent Fatty Acids 89, 55-63.
30. Gradinaru D, Borsa C, Ionescu C & Prada GI (2015). Oxidized LDL and NO synthesis - Biomarkers of endothelial dysfunction and ageing. Mech Ageing Dev 151, 101-113.
31. Hamilton CA, Brosnan MJ, McIntyre M, Graham D & Dominiczak AF (2001). Superoxide excess in hypertension and aging: a common cause of endothelial dysfunction. Hypertension 37, 529-534.
32. Harrison DG (1997). Endothelial function and oxidant stress. Clin Cardiol 20, II-11-17.
33. Harvey A, Montezano A & Touyz RM (2015). Vascular biology of ageing - implications in hypertension. J Mol Cell Cardiol 83, 112-121.
34. Helmschrodt C, Becker S, Schröter J, Hecht M, Aust G, Thiery J & Ceglarek U (2013). Fast LC-MS/MS analysis of free oxysterols derived from reactive oxygen species in human plasma and carotid plaque. Clin Chim Acta 425, 3-8.
35. Huynh J, Nishimura N, Rana K, Peloquin JM, Califano JP, Montague CR, King MR, Schaffer CB & Reinhart-King CA (2011). Age-related intimal stiffening enhances endothelial permeability and leukocyte transmigration. Sci Transl Med 3, 112ra122.
36. Iuliano L, Micheletta F, Natoli S, Ginanni Corradini S, Iappelli M, Elisei W, Giovannelli L, Violi F & Diczfalusy U (2003). Measurement of oxysterols and α-tocopherol in plasma and tissue samples as indices of oxidant stress status. Anal Biochem 312, 217-223.
37. Kha HT, Basseri B, Shouhed D, Richardson J, Tetradis S, Hahn TJ & Parhami F (2004). Oxysterols regulate differentiation of mesenchymal stem cells: pro-bone and antifat. J Bone Miner Res 19, 830-840.
38. Khatib S & Vaya J (2014). Oxysterols and symptomatic versus asymptomatic human atherosclerotic plaque. Biochem Biophys Res Commun 446, 709-713.
39. Kim SM, Jang H, Son Y, Lee SA, Bae SS, Park YE, Eo SK & Kim K (2013). 27-Hydroxycholesterol induces production of tumor necrosis factor-alpha from macrophages. Biochem Biophys Res Commun 430, 454-459.
40. Kim SM, Kim BY, Eo SK, Kim CD & Kim K (2015). 27-Hydroxycholesterol up-regulates CD14 and predisposes monocytic cells to superproduction of CCL2 in response to lipopolysaccharide. Biochim Biophys Acta 1852, 442-450.
41. Kokoszka JE, Coskun P, Esposito LA & Wallace DC (2001). Increased mitochondrial oxidative stress in the Sod2 (+/-) mouse results in the age-related decline of mitochondrial function culminating in increased apoptosis. Proc Natl Acad Sci USA 98, 2278-2283.
42. Krause KH (2007). Aging: a revisited theory based on free radicals generated by NOX family NADPH oxidases. Exp Gerontol 42, 256-262.
43. Kwon IK, Lee SC, Hwang YS & Heo JS (2015). Mitochondrial function contributes to oxysterol-induced osteogenic differentiation in mouse embryonic stem cells. Biochim Biophys Acta 1854, 561-572.
44. Lakatta EG (2013). The reality of aging viewed from the arterial wall. Artery Res 7, 73-80.
45. Landis MS, Patel HV & Capone JP (2002). Oxysterol activators of liver X receptor and 9-cis-retinoic acid promote sequential steps in the synthesis and secretion of tumor necrosis factor-α from human monocytes. J Biol Chem 277, 4713-4721.
46. Lee HS, Chang J, Baek JA, Chung MY, Lee HC, Rhim BY, Sok DE, Rho MC, Kim YK & Kim K (2005). TNF-α activates death pathway in human aorta smooth muscle cell in the presence of 7-ketocholesterol. Biochem Biophys Res Commun 333, 1093-1099.
47. Lemaire S, Lizard G, Monier S, Miguet C, Gueldry S, Volot F, Gambert P & Néel D (1998). Different patterns of IL-1β secretion, adhesion molecule expression and apoptosis induction in human endothelial cells treated with 7α-, 7β-hydroxycholesterol, or 7-ketocholesterol. FEBS Lett 440, 434-439.
48. Lemaire-Ewing S, Berthier A, Royer MC, Logette E, Corcos L, Bouchot A, Monier S, Prunet C, Raveneau M, Rébé C, Desrumaux C, Lizard G & Néel D (2009). 7β-Hydroxycholesterol and 25-hydroxycholesterol-induced interleukin-8 secretion involves a calcium-dependent activation of c-fos via the ERK1/2 signaling pathway in THP-1 cells: oxysterols-induced IL-8 secretion is calcium-dependent. Cell Biol Toxicol 25, 127-139.
49. Leonarduzzi G, Gamba P, Gargiulo S, Biasi F & Poli G (2012). Inflammation-related gene expression by lipid oxidation-derived products in the progression of atherosclerosis. Free Radic Biol Med 52, 19-34.
50. Leonarduzzi G, Gamba P, Gargiulo S, Sottero B, Kadl A, Biasi F, Chiarpotto E, Leitinger N, Vendemiale G, Serviddio G & Poli G (2008). Oxidation as a crucial reaction for cholesterol to induce tissue degeneration: CD36 overexpression in human promonocytic cells treated with a biologically relevant oxysterol mixture. Aging Cell 7, 375-382.
51. Leonarduzzi G, Gamba P, Sottero B, Kadl A, Robbesyn F, Calogero R, Biasi F, Chiarpotto E, Leitinger N, Sevanian A & Poli G (2005). Oxysterol-induced up-regulation of MCP-1 expression and synthesis in macrophage cells. Free Radic Biol Med 39, 1152-1161.
52. Leonarduzzi G, Gargiulo S, Gamba P, Perrelli MG, Castellano I, Sapino A, Sottero B & Poli G (2010). Molecular signaling operated by a diet-compatible mixture of oxysterols in up-regulating CD36 receptor in CD68 positive cells. Mol Nutr Food Res 54, Suppl. 1, S31-41.
53. Leonarduzzi G, Poli G, Sottero B & Biasi F (2007). Activation of the mitochondrial pathway of apoptosis by oxysterols. Front Biosci 12, 791-799.
54. Leonarduzzi G, Sevanian A, Sottero B, Arkan MC, Biasi F, Chiarpotto E, Basaga H & Poli G (2001). Up-regulation of the fibrogenic cytokine TGF-β1 by oxysterols: a mechanistic link between cholesterol and atherosclerosis. FASEB J 15, 1619-1621.
55. Li HX, Kong FJ, Bai SZ, He W, Xing WJ, Xi YH, Li GW, Guo J, Li HZ, Wu LY, Wang R, Yang GD, Tian Y & Xu CQ (2012). Involvement of calcium-sensing receptor in oxLDL-induced MMP-2 production in vascular smooth muscle cells via PI3K/Akt pathway. Mol Cell Biochem 362, 115-122.
56. Li W, Ghosh M, Eftekhari S & Yuan XM (2011). Lipid accumulation and lysosomal pathways contribute to dysfunction and apoptosis of human endothelial cells caused by 7-oxysterols. Biochem Biophys Res Commun 409, 711-716.
57. Li W, Laskar A, Sultana N, Osman E, Ghosh M, Li Q & Yuan XM (2012). Cell death induced by 7-oxysterols via lysosomal and mitochondrial pathways is p53-dependent. Free Radic Biol Med 53, 2054-2061.
58. Li Z, Froehlich J, Galis Z & Lakatta EG (1999). Increased expression of matrix metalloproteinase-2 in the thickened intima of aged rats. Hypertension 33, 116-123.
59. Liao P, Cheng Y, Li C, Wang YT & Kang J (2010). 7-Ketocholesterol and cholesterol-5α, 6α-epoxide induce smooth muscle cell migration and proliferation through the epidermal growth factor receptor/phosphoinositide 3-kinase/Akt signaling pathways. Toxicol Lett 197, 88-96.
60. 2/M phase in the human monocytic THP-1 cell line. Life Sci 72, 1389-1399.
61. Liu H, Yuan L, Xu S, Zhang T & Wang K (2004). Cholestane-3β, 5α, 6β-triol promotes vascular smooth muscle cells calcification. Life Sci 76, 533-543.
62. Liu J, Ren Y, Kang L & Zhang L (2014). Oxidized low-density lipoprotein increases the proliferation and migration of human coronary artery smooth muscle cells through the upregulation of osteopontin. Int J Mol Med 33, 1341-1347.
63. Lizard G, Gueldry S, Sordet O, Monier S, Athias A, Miguet C, Bessede G, Lemaire S, Solary E & Gambert P (1998). Glutathione is implied in the control of 7-ketocholesterol-induced apoptosis, which is associated with radical oxygen species production. FASEB J 12, 1651-1663.
64. Lordan S, Mackrill JJ & O'Brien NM (2009). Oxysterols and mechanisms of apoptotic signaling: implications in the pathology of degenerative diseases. J Nutr Biochem 20, 321-336.
65. Luchetti F, Canonico B, Cesarini E, Betti M, Galluzzi L, Galli L, Tippins J, Zerbinati C, Papa S & Iuliano L (2015). 7-Ketocholesterol and 5, 6-secosterol induce human endothelial cell dysfunction by differential mechanisms. Steroids 99, 204-211.
66. Lusis AJ (2000). Atherosclerosis. Nature 407, 233-241.
67. McCarthy MF & DiNicolantonio JJ (2014). The molecular biology and pathophysiology of vascular calcification. Postgrad Med 126, 54-64.
68. Mascia C, Maina M, Chiarpotto E, Leonarduzzi G, Poli G & Biasi F (2010). Proinflammatory effect of cholesterol oxidation products on CaCo-2 human enterocyte-like cells: effective protection by epigallocathechin-3-gallate. Free Radic Biol Med 49, 2049-2057.
69. Mateos L, Ismail M, Gil-Bea F, Schüle R, Schöls L, Heverin M, Folkesson R, Björkhem I & Cedazo-Mínguez A (2011). Side chain-oxidized oxysterols regulate the brain renin-angiotensin system through a liver X receptor-dependent mechanism. J Biol Chem 286, 25574-25585.
70. Miah S, Zadeh SN, Yuan XM & Li W (2013). Expression of Egr1 and p53 in human carotid plaques and apoptosis induced by 7-oxysterol or p53. Exp Toxicol Pathol 65, 677-682.
71. Michel T & Vanhoutte PM (2010). Cellular signaling and NO production. Pflugers Arch 459, 807-816.
72. Micheletta F, Natoli S, Misuraca M, Sbarigia E, Diczfalusy U & Iuliano L (2004). Vitamin E supplementation in patients with carotid atherosclerosis: reversal of altered oxidative stress status in plasma but not in plaque. Arterioscler Thromb Vasc Biol 24, 136-140.
73. Moncada S, Palmer R & Higgs E (1991). Nitric oxide: physiology, pathophysiology, and pharmacology. Pharmacol Rev 43, 109-142.
74. Monk BA & George SJ (2014). The effect of ageing on vascular smooth muscle cell behaviour - a mini-review. Gerontology 61, 416-426.
75. Montezano AC, Burger D, Ceravolo GS, Yusuf H, Montero M & Touyz RM (2011). Novel Nox homologues in the vasculature: focusing on Nox4 and Nox5. Clin Sci (Lond) 120, 131-141.
76. Montezano AC, Nguyen Dinh Cat A, Rios FJ & Touyz RM (2014). Angiotensin II and vascular injury. Curr Hypertens Rep 16, 431.
77. Montezano AC & Touyz RM (2012). Molecular mechanisms of hypertension - reactive oxygen species and antioxidants: a basic science update for the clinician. Can J Cardiol 28, 288-295.
78. 1 blockade and cholesterol-dependent oxidative stress: the EPAS trial. Circulation 114, I296-301.
79. Naito Y, Shimozawa M, Kuroda M, Nakabe N, Manabe H, Katada K, Kokura S, Ichikawa H, Yoshida N, Noguchi N & Yoshikawa T (2005). Tocotrienols reduce 25-hydroxycholesterol-induced monocyte-endothelial cell interaction by inhibiting the surface expression of adhesion molecules. Atherosclerosis 180, 19-25.
80. Nury T, Zarrouk A, Mackrill JJ, Samadi M, Durand P, Riedinger JM, Doria M, Vejux A, Limagne E, Delmas D, Prost M, Moreau T, Hammami M, Delage-Mourroux R, O'Brien NM & Lizard G (2015). Induction of oxiapoptophagy on 158N murine oligodendrocytes treated by 7-ketocholesterol-, 7β-hydroxycholesterol-, or 24(S)-hydroxycholesterol: Protective effects of α-tocopherol and docosahexaenoic acid (DHA; C22:6 n-3). Steroids 99, 194-203.
81. 1 receptor blockers suppress oxidized low-density lipoprotein-derived formation of foam cells. Eur J Pharmacol 679, 9-15.
82. Parthasarathy S, Raghavamenon A, Garelnabi MA & Santanam N (2010). Oxidized low-density lipoprotein. Methods Mol Biol 610, 403-417.
83. Pedruzzi E, Guichard C, Ollivier V, Driss F, Fay M, Prunet C, Marie JC, Pouzet C, Samadi M, Elbim C, O'Dowd Y, Bens M, Vandewalle A, Gougerot-Pocidalo MA, Lizard G & Ogier-Denis E (2004). NAD(P)H oxidase Nox-4 mediates 7-ketocholesterol-induced endoplasmic reticulum stress and apoptosis in human aortic smooth muscle cells. Mol Cell Biol 24, 10703-10717.
84. Peng SK, Hu B, Peng AY & Morin R (1993). Effect of cholesterol oxides on prostacyclin production and platelet adhesion. Artery 20, 122-134.
85. Poli G, Biasi F & Leonarduzzi G (2013). Oxysterols in the pathogenesis of major chronic diseases. Redox Biol 1, 125-130.
86. Poli G, Sottero B, Gargiulo S & Leonarduzzi G (2009). Cholesterol oxidation products in the vascular remodeling due to atherosclerosis. Mol Aspects Med 30, 180-189.
87. Proudfoot D, Skepper JN, Hegyi L, Bennett MR, Shanahan CM & Weissberg PL (2000). Apoptosis regulates human vascular calcification in vitro: evidence for initiation of vascular calcification by apoptotic bodies. Circ Res 87, 1055-1062.
88. Prunet C, Montange T, Véjux A, Laubriet A, Rohmer JF, Riedinger JM, Athias A, Lemaire-Ewing S, Néel D, Petit JM, Steinmetz E, Brenot R, Gambert P & Lizard G (2006). Multiplexed flow cytometric analyses of pro- and anti-inflammatory cytokines in the culture media of oxysterol-treated human monocytic cells and in the sera of atherosclerotic patients. Cytometry A 69, 359-373.
89. Puca A, Carrizzo A, Villa F, Ferrario A, Casaburo M, Maciag A & Vecchione C (2013). Vascular ageing: the role of oxidative stress. Int J Biochem Cell Biol 45, 556-559.
90. Quarles EK, Dai DF, Tocchi A, Basisty N, Gitari L & Rabinovitch PS (2015). Quality control systems in cardiac aging. Ageing Res Rev 23, 101-115.
91. Ramasamy S, Boissonneault GA & Hennig B (1992). Oxysterol-induced endothelial cell dysfunction in culture. J Am Coll Nutr 11, 532-538.
92. Ryan L, O'Callaghan YC & O'Brien NM (2004). Generation of an oxidative stress precedes caspase activation during 7β-hydroxycholesterol-induced apoptosis in U937 cells. J Biochem Mol Toxicol 18, 50-59.
93. Saito E, Wachi H, Sato F & Seyama Y (2008). 7-Ketocholesterol, a major oxysterol, promotes Pi-induced vascular calcification in cultured smooth muscle cells. J Atheroscler Thromb 15, 130-137.
94. Sato K, Nakano K, Katsuki S, Matoba T, Osada K, Sawamura T, Sunagawa K & Egashira K (2012). Dietary cholesterol oxidation products accelerate plaque destabilization and rupture associated with monocyte infiltration/activation via the MCP-1-CCR2 pathway in mouse brachiocephalic arteries: therapeutic effects of ezetimibe. J Atheroscler Thromb 19, 986-998.
95. Schiffrin EL & Touyz RM (2004). From bedside to bench to bedside: role of renin-angiotensin-aldosterone system in remodeling of resistance arteries in hypertension. Am J Physiol Heart Circ Physiol 287, H435-H446.
96. Shentu TP, Singh DK, Oh M, Sun S, Sadaat L, Makino A, Mazzone T, Subbaiah PV, Cho M & Levitan I (2012). The role of oxysterols in control of endothelial stiffness. J Lipid Res 53, 1348-1358.
97. Shentu TP, Titushkin I, Singh DK, Gooch KJ, Subbaiah PV, Cho M & Levitan I (2010). oxLDL-induced decrease in lipid order of membrane domains is inversely correlated with endothelial stiffness and network formation. Am J Physiol Cell Physiol 299, C218-C229.
98. Sinha K, Das J, Pal PB & Sil PC (2013). Oxidative stress: the mitochondria-dependent and mitochondria-independent pathways of apoptosis. Arch Toxicol 87, 1157-1180.
99. Sleer LS, Brown AJ & Stanley KK (2001). Interaction of caveolin with 7-ketocholesterol. Atherosclerosis 159, 49-55.
100. Sottero B, Gamba P, Gargiulo S, Leonarduzzi G & Poli G (2009). Cholesterol oxidation products and disease: an emerging topic of interest in medicinal chemistry. Curr Med Chem 16, 685-705.
101. Szklarczyk R, Nooteboom M & Osiewacz HD (2014). Control of mitochondrial integrity in ageing and disease. Philos Trans R Soc Lond B Biol Sci 369, 20130439.
102. Taddei S, Virdis A, Ghiadoni L, Salvetti G, Bernini G, Magagna A & Salvetti A (2001). Age-related reduction of NO availability and oxidative stress in human. Hypertension 38, 274-279.
103. Tang R, Liu H, Wang T & Huang K (2005). Mechanisms of selenium inhibition of cell apoptosis induced by oxysterols in rat vascular smooth muscle cells. Arch Biochem Biophys 441, 16-24.
104. Tian XL & Li Y (2014). Endothelial cell senescence and age-related vascular diseases. J Genet Genomics 41, 485-495.
105. Upston JM, Niu X, Brown AJ, Mashima R, Wang H, Senthilmohan R, Kettle AJ, Dean RT & Stocker R (2002). Disease stage-dependent accumulation of lipid and protein oxidation products in human atherosclerosis. Am J Pathol 160, 701-710.
106. Usatyuk PV, Parinandi NL & Natarajan V (2006). Redox regulation of 4-hydroxy-2-nonenal-mediated endothelial barrier dysfunction by focal adhesion, adherens, and tight junction proteins. J Biol Chem 281, 35554-35566.
107. Usatyuk PV & Natarajan V (2012). Hydroxyalkenals and oxidized phospholipids modulation of endothelial cytoskeleton, focal adhesion and adherens junction proteins in regulating endothelial barrier function. Microvasc Res 83, 45-55.
108. Vaya J, Aviram M, Mahmood S, Hayek T, Grenadir E, Hoffman A & Milo S (2001). Selective distribution of oxysterols in atherosclerotic lesions and human plasma lipoproteins. Free Radic Res 34, 485-497.
109. Vejux A, Guyot S, Montange T, Riedinger JM, Kahn E & Lizard G (2009). Phospholipidosis and down-regulation of the PI3-K/PDK-1/Akt signalling pathway are vitamin E inhibitable events associated with 7-ketocholesterol-induced apoptosis. J Nutr Biochem 20, 45-61.
110. Virginio VW, Nunes VS, Moura FA, Menezes FH, Andreollo NA, Rogerio F, Scherrer DZ, Quintão EC, Nakandakare E, Petrucci O, Nadruz-Junior W, de Faria EC & Sposito AC (2015). Arterial tissue and plasma concentration of enzymatic-driven oxysterols are associated with severe peripheral atherosclerotic disease and systemic inflammatory activity. Free Radic Res 49, 199-203.
111. Vurusaner B, Gamba P, Testa G, Gargiulo S, Biasi F, Zerbinati C, Iuliano L, Leonarduzzi G, Basaga H & Poli G (2014). Survival signaling elicited by 27-hydroxycholesterol through the combined modulation of cellular redox state and ERK/Akt phosphorylation. Free Radic Biol Med 77, 376-385.
112. Wang JC & Bennett M (2012). Aging and atherosclerosis: mechanisms, functional consequences, and potential therapeutics for cellular senescence. Circ Res 111, 245-259.
113. Wang M, Jiang L, Monticone RE & Lakatta EG (2014). Proinflammation: the key of arterial aging. Trends Endocrinol Metab 25, 72-80.
114. Watson KE, Boström K, Ravindranath R, Lam T, Norton B & Demer L (1994). TGF-beta 1 and 25-hydroxycholesterol stimulate osteoblast-like vascular cells to calcify. J Clin Invest 93, 2106-2113.
115. Wind S, Beuerlein K, Armitage M, Taye A, Kumar A, Janowitz D, Neff C, Shah AM, Wingler K & Schmidt HH (2010). Oxidative stress and endothelial dysfunction in aortas of aged spontaneously hypertensive rats by NOX1/2 is reversed by NADPH oxidase inhibition. Hypertension 56, 490-497.
116. Wohlfeil ER & Campbel WB (1999). 25-Hydroxycholesterol increases eicosanoids and alters morphology in cultured pulmonary artery smooth muscle and endothelial cells. Arterioscler Thromb Vasc Biol 19, 2901-2908.
117. Wöltje M, Böbel M, Heiland M, Beck-Broichsitter B, Al-Dam A, Gröbe A, Friedrich RE, Hanken H & Smeets R (2015). Purmorphamine and oxysterols accelerate and promote osteogenic differentiation of mesenchymal stem cells in vitro. In Vivo 29, 247-254.
118. Wong W, Ng CH, Tsang SY, Huang Y & Chen ZY (2011). Relative contribution of individual oxidized components in ox-LDL to inhibition on endothelium-dependent relaxation in rat aorta. Nutr Metab Cardiovasc Dis 21, 157-164.
119. Yamamoto KK, Takeshita H, Hayashi N, Li L, Nakano A, Hanasaki-Yamamoto H, Fujita Y, Imaizumi Y, Toyama-Yokoyama S, Nakama C, Kawai T, Takeda M, Hongyo K, Oguro R, Maekawa Y, Itoh N, Takami Y, Onishi M, Takeya Y, Sugimoto K, Kamide K, Nakagami H, Ohishi M, Kurtz TW, Sawamura T & Rakugi H (2015). Oxidized LDL (oxLDL) activates the angiotensin II type 1 receptor by binding to the lectin-like oxLDL receptor. FASEB J 29, 3342-3356.
120. Yang D, McCrann DJ, Nguyen H, St Hilaire C, DePinho RA, Jones MR & Ravid K (2007). Increased polyploidy in aortic vascular smooth muscle cells during aging is marked by cellular senescence. Aging Cell 6, 257-260.
121. Yang L & Sinensky M (2000). 25-Hydroxycholesterol activates a cytochrome c release-mediated caspase cascade. Biochem Biophys Res Commun 278, 557-563.
122. Yuan XM, Osman E, Miah S, Zadeh SN, Xu L, Forssell C & Li W (2010). p53 expression in human carotid atheroma is significantly related to plaque instability and clinical manifestations. Atherosclerosis 210, 392-399.
123. Zarkovic K, Larroque-Cardoso P, Pucelle M, Salvayre R, Waeg G, Nègre-Salvayre A & Zarkovic N (2015). Elastin aging and lipid oxidation products in human aorta. Redox Biol 4, 109-117.
124. Zarrouk A, Vejux A, Mackrill J, O'Callaghan Y, Hammami M, O'Brien N & Lizard G (2014). Involvement of oxysterols in age-related diseases and ageing processes. Ageing Res Rev 18, 148-162.
125. Zarzuelo M, López-Sepúlveda R, Sánchez M, Romero M, Gómez-Guzmán M, Ungvary Z, Pérez-Vizcaíno F, Jiménez R & Duarte J (2013). SIRT1 inhibits NADPH oxidase activation and protects endothelial function in the rat aorta: implications for vascular aging. Biochem Pharmacol 85, 1288-1296.